Functional characterization of SDHB variants clarifies hereditary pheochromocytoma and paraganglioma risk and genotype-phenotype relationships
Journal of Clinical Investigation · 16.02.2026 · 136 (4)
DOI: 10.1172/jci198165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 18.11.2025. Verfasst von Sooyeon Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology and. Hauptthemen laut MEDLINE: Succinate Dehydrogenase, Pheochromocytoma, Paraganglioma, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH NIDDK, Neuroendocrine Tumor Research Foundation.
Abstract (Originalsprache)
Hereditary pheochromocytoma and paraganglioma (hPPGL) is caused by pathogenic mutations in succinate dehydrogenase (SDH) genes, commonly SDHB . However, over 80% of SDHB missense variants are classified as variants of uncertain significance (VUS), limiting clinical interpretation and diagnostic utility of germline testing. To provide functional evidence of SDHB allele pathogenicity or benignity, we developed a cellular complementation assay that quantifies intracellular succinate/fumarate ratios as a readout of SDH enzymatic activity. This assay reliably distinguished pathogenic from benign alleles with high fidelity, outperforming and complementing computational predictions. Functional assessment of patient-derived VUS alleles supported reclassification of 87% of tested variants and revealed that mutations in the iron-sulfur cluster domain were amorphic, while those at or beyond the C-terminal residue Tyr273 retained function. Variants associated with Leigh syndrome retained activity, consistent with their biallelic inheritance and distinct pathogenic mechanisms from SDHB -related tumorigenesis. Notably, hypomorphic pathogenic SDHB variants correlated with increased head and neck paraganglioma occurrence, revealing a genotype-phenotype relationship. Functional characterization of SDHB missense variants supports clinical classification, informs hPPGL risk stratification, and has immediate diagnostic impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Endocrinology and.
- Department of Medicine, Division of Oncology, Stanford University, Stanford, California, USA.
- Stanford ChEM-H and Endocrine Oncology, Stanford University Cancer Institute, Stanford, California, USA.
Förderung
- NIDDK NIH HHS
- NIH NIDDK
- Neuroendocrine Tumor Research Foundation
Zitieren
APA
Lee, S., Needleman, L., Park, J., Schugar, R. C., Guo, Q., Ford, J. M., & Annes, J. P. (2026). Functional characterization of SDHB variants clarifies hereditary pheochromocytoma and paraganglioma risk and genotype-phenotype relationships. Journal of Clinical Investigation, 136(4). https://doi.org/10.1172/jci198165
Vancouver
Lee S, Needleman L, Park J, Schugar RC, Guo Q, Ford JM, et al. Functional characterization of SDHB variants clarifies hereditary pheochromocytoma and paraganglioma risk and genotype-phenotype relationships. Journal of Clinical Investigation. 2026;136(4). doi:10.1172/jci198165
BibTeX
@article{Lee2026,
author = {Lee, Sooyeon and Needleman, Leor and Park, Julie and Schugar, Rebecca C and Guo, Qianjin and Ford, James M and Annes, Justin P},
title = {Functional characterization of SDHB variants clarifies hereditary pheochromocytoma and paraganglioma risk and genotype-phenotype relationships},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {4},
doi = {10.1172/jci198165}
}
EUVIMED